Kingsview Wealth Management LLC Buys 13,442 Shares of Cigna Group $CI

Kingsview Wealth Management LLC lifted its position in Cigna Group (NYSE:CI) by 37.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 48,994 shares of the health services provider’s stock after purchasing an additional 13,442 shares during the period. Kingsview Wealth Management LLC’s holdings in Cigna Group were worth $14,122,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Pathway Financial Advisers LLC lifted its holdings in shares of Cigna Group by 2.3% in the 2nd quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after buying an additional 34 shares during the period. Armstrong Advisory Group Inc. increased its stake in shares of Cigna Group by 17.7% during the third quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after buying an additional 34 shares during the period. HM Payson & Co. raised its holdings in shares of Cigna Group by 0.9% in the third quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock valued at $1,091,000 after acquiring an additional 35 shares in the last quarter. Carr Financial Group Corp lifted its stake in Cigna Group by 5.3% in the third quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock worth $204,000 after acquiring an additional 36 shares during the period. Finally, Natural Investments LLC grew its holdings in Cigna Group by 2.0% during the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock worth $531,000 after acquiring an additional 36 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of CI opened at $289.73 on Monday. The company has a 50 day moving average of $279.98 and a two-hundred day moving average of $284.54. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The company has a market cap of $77.39 billion, a price-to-earnings ratio of 13.06, a price-to-earnings-growth ratio of 1.01 and a beta of 0.27.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be issued a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s dividend payout ratio is 28.13%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on CI shares. JPMorgan Chase & Co. reduced their price target on shares of Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a report on Tuesday, November 4th. Sanford C. Bernstein reissued a “market perform” rating and issued a $307.00 price objective on shares of Cigna Group in a research note on Tuesday, January 6th. Wells Fargo & Company lowered their target price on Cigna Group from $354.00 to $300.00 and set an “equal weight” rating for the company in a report on Wednesday, November 5th. The Goldman Sachs Group dropped their target price on Cigna Group from $370.00 to $330.00 and set a “buy” rating on the stock in a research report on Tuesday, November 4th. Finally, Mizuho set a $325.00 price target on Cigna Group in a report on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $330.63.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.